Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$5.23 - $7.18 $1,506 - $2,067
-288 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$7.54 - $9.79 $573 - $744
-76 Reduced 20.88%
288 $2,000
Q1 2021

May 14, 2021

BUY
$4.76 - $11.25 $361 - $855
76 Added 26.39%
364 $4,000
Q2 2020

Aug 13, 2020

BUY
$1.33 - $3.63 $381 - $1,041
287 Added 28700.0%
288 $1,000
Q4 2019

Feb 12, 2020

BUY
$1.3 - $2.72 $1 - $2
1 New
1 $0

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.